Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 111

1.

Impact of correlation on predictive ability of biomarkers.

Demler OV, Pencina MJ, D'Agostino RB Sr.

Stat Med. 2013 Oct 30;32(24):4196-210. doi: 10.1002/sim.5824. Epub 2013 May 3.

2.

Equivalence of improvement in area under ROC curve and linear discriminant analysis coefficient under assumption of normality.

Demler OV, Pencina MJ, D'Agostino RB Sr.

Stat Med. 2011 May 30;30(12):1410-8. doi: 10.1002/sim.4196. Epub 2011 Feb 21.

PMID:
21337594
3.

Assessing the incremental predictive performance of novel biomarkers over standard predictors.

Xanthakis V, Sullivan LM, Vasan RS, Benjamin EJ, Massaro JM, D'Agostino RB Sr, Pencina MJ.

Stat Med. 2014 Jul 10;33(15):2577-84. doi: 10.1002/sim.6165. Epub 2014 Apr 9.

4.

Testing for improvement in prediction model performance.

Pepe MS, Kerr KF, Longton G, Wang Z.

Stat Med. 2013 Apr 30;32(9):1467-82. doi: 10.1002/sim.5727. Epub 2013 Jan 7.

5.

Sufficient dimension reduction for longitudinally measured predictors.

Pfeiffer RM, Forzani L, Bura E.

Stat Med. 2012 Sep 28;31(22):2414-27. doi: 10.1002/sim.4437. Epub 2011 Dec 9.

PMID:
22161635
6.

Interpreting incremental value of markers added to risk prediction models.

Pencina MJ, D'Agostino RB, Pencina KM, Janssens AC, Greenland P.

Am J Epidemiol. 2012 Sep 15;176(6):473-81. Epub 2012 Aug 8.

7.

Understanding increments in model performance metrics.

Pencina MJ, D'Agostino RB, Massaro JM.

Lifetime Data Anal. 2013 Apr;19(2):202-18. doi: 10.1007/s10985-012-9238-0. Epub 2012 Dec 16.

8.

Evaluating the incremental value of new biomarkers with integrated discrimination improvement.

Kerr KF, McClelland RL, Brown ER, Lumley T.

Am J Epidemiol. 2011 Aug 1;174(3):364-74. doi: 10.1093/aje/kwr086. Epub 2011 Jun 14.

9.

Novel metrics for evaluating improvement in discrimination: net reclassification and integrated discrimination improvement for normal variables and nested models.

Pencina MJ, D'Agostino RB Sr, Demler OV.

Stat Med. 2012 Jan 30;31(2):101-13. doi: 10.1002/sim.4348. Epub 2011 Dec 7.

10.

Assessment of claims of improved prediction beyond the Framingham risk score.

Tzoulaki I, Liberopoulos G, Ioannidis JP.

JAMA. 2009 Dec 2;302(21):2345-52. doi: 10.1001/jama.2009.1757. Review.

PMID:
19952321
11.
12.

Improved cardiovascular risk prediction using nonparametric regression and electronic health record data.

Kennedy EH, Wiitala WL, Hayward RA, Sussman JB.

Med Care. 2013 Mar;51(3):251-8. doi: 10.1097/MLR.0b013e31827da594.

13.

Adaptive index models for marker-based risk stratification.

Tian L, Tibshirani R.

Biostatistics. 2011 Jan;12(1):68-86. doi: 10.1093/biostatistics/kxq047. Epub 2010 Jul 27.

14.

Prediction of an outcome using trajectories estimated from a linear mixed model.

Maruyama N, Takahashi F, Takeuchi M.

J Biopharm Stat. 2009 Sep;19(5):779-90. doi: 10.1080/10543400903105174.

PMID:
20183443
15.

An assessment of the relationship between clinical utility and predictive ability measures and the impact of mean risk in the population.

McGeechan K, Macaskill P, Irwig L, Bossuyt PM.

BMC Med Res Methodol. 2014 Jul 3;14:86. doi: 10.1186/1471-2288-14-86.

16.

Identification of biomarkers for risk stratification of cardiovascular events using genetic algorithm with recursive local floating search.

Zhou X, Wang H, Wang J, Wang Y, Hoehn G, Azok J, Brennan ML, Hazen SL, Li K, Chang SF, Wong ST.

Proteomics. 2009 Apr;9(8):2286-94. doi: 10.1002/pmic.200700867.

PMID:
19337989
17.

One statistical test is sufficient for assessing new predictive markers.

Vickers AJ, Cronin AM, Begg CB.

BMC Med Res Methodol. 2011 Jan 28;11:13. doi: 10.1186/1471-2288-11-13.

18.

On the assessment of the added value of new predictive biomarkers.

Chen W, Samuelson FW, Gallas BD, Kang L, Sahiner B, Petrick N.

BMC Med Res Methodol. 2013 Jul 29;13:98. doi: 10.1186/1471-2288-13-98.

19.

A Bayesian prediction model between a biomarker and the clinical endpoint for dichotomous variables.

Jiang Z, Song Y, Shou Q, Xia J, Wang W.

Trials. 2014 Dec 20;15:500. doi: 10.1186/1745-6215-15-500.

20.

Subgroup specific incremental value of new markers for risk prediction.

Zhou QM, Zheng Y, Cai T.

Lifetime Data Anal. 2013 Apr;19(2):142-69. doi: 10.1007/s10985-012-9235-3. Epub 2012 Dec 23.

Items per page

Supplemental Content

Write to the Help Desk